Shandong Realcan Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Shandong Realcan Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shandong Realcan Pharmaceutical Co Ltd (002589) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-15.60 Million ≈ $-2.28 Million USD) by net assets (CN¥5.45 Billion ≈ $798.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002589 market cap overview for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Shandong Realcan Pharmaceutical Co Ltd (2008–2025)

Cash flow conversion efficiency of Shandong Realcan Pharmaceutical Co Ltd from 2008 to 2025. This chart illustrates how Shandong Realcan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shandong Realcan Pharmaceutical Co Ltd (002589) stock price for real-time trading data and today's change.

Shandong Realcan Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Shandong Realcan Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shandong Realcan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Realcan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Review Shandong Realcan Pharmaceutical Co Ltd (002589) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Archean Chemical Industries Limited NSE:ACI	0.018x
Guangzhou Boji Medical and Biotechnological Co Ltd SHE:300404	-0.007x
Electronics Mart India Limited NSE:EMIL	0.167x
Kunshan Top A Intelligent Equipment SHE:300836	-0.017x
Phenix Optical Co Ltd SHG:600071	0.083x
Miracll Chemicals Co Ltd SHE:300848	0.054x
Cancom SE F:COK	-0.102x
GFT Technologies SE XETRA:GFT	-0.020x

Annual Cash Flow Conversion Efficiency for Shandong Realcan Pharmaceutical Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Shandong Realcan Pharmaceutical Co Ltd from 2008 to 2025. Also see how large is Shandong Realcan Pharmaceutical Co Ltd's balance sheet for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.42 Billion ≈ $793.52 Million	CN¥13.76 Million ≈ $2.01 Million	0.003x	-90.99%
2024-12-31	CN¥5.69 Billion ≈ $833.30 Million	CN¥160.44 Million ≈ $23.48 Million	0.028x	+92.59%
2023-12-31	CN¥5.64 Billion ≈ $824.87 Million	CN¥82.47 Million ≈ $12.07 Million	0.015x	-83.91%
2022-12-31	CN¥5.75 Billion ≈ $841.67 Million	CN¥523.07 Million ≈ $76.54 Million	0.091x	+99.01%
2021-12-31	CN¥9.69 Billion ≈ $1.42 Billion	CN¥442.95 Million ≈ $64.82 Million	0.046x	+6.19%
2020-12-31	CN¥9.64 Billion ≈ $1.41 Billion	CN¥414.96 Million ≈ $60.72 Million	0.043x	-78.93%
2019-12-31	CN¥10.25 Billion ≈ $1.50 Billion	CN¥2.09 Billion ≈ $306.49 Million	0.204x	+1245.34%
2018-12-31	CN¥11.31 Billion ≈ $1.65 Billion	CN¥-201.66 Million ≈ $-29.51 Million	-0.018x	+92.88%
2017-12-31	CN¥9.67 Billion ≈ $1.42 Billion	CN¥-2.42 Billion ≈ $-354.40 Million	-0.250x	-6.78%
2016-12-31	CN¥7.50 Billion ≈ $1.10 Billion	CN¥-1.76 Billion ≈ $-257.40 Million	-0.234x	-71.19%
2015-12-31	CN¥3.40 Billion ≈ $498.16 Million	CN¥-466.26 Million ≈ $-68.23 Million	-0.137x	-52.79%
2014-12-31	CN¥1.83 Billion ≈ $267.10 Million	CN¥-163.62 Million ≈ $-23.94 Million	-0.090x	+46.11%
2013-12-31	CN¥1.65 Billion ≈ $241.45 Million	CN¥-274.46 Million ≈ $-40.16 Million	-0.166x	+10.61%
2012-12-31	CN¥916.39 Million ≈ $134.10 Million	CN¥-170.52 Million ≈ $-24.95 Million	-0.186x	+67.99%
2011-12-31	CN¥817.11 Million ≈ $119.57 Million	CN¥-475.03 Million ≈ $-69.51 Million	-0.581x	-343.92%
2010-12-31	CN¥296.03 Million ≈ $43.32 Million	CN¥70.56 Million ≈ $10.32 Million	0.238x	-9.07%
2009-12-31	CN¥234.18 Million ≈ $34.27 Million	CN¥61.38 Million ≈ $8.98 Million	0.262x	+158.80%
2008-12-31	CN¥111.89 Million ≈ $16.37 Million	CN¥-49.88 Million ≈ $-7.30 Million	-0.446x	--

About Shandong Realcan Pharmaceutical Co Ltd

SHE:002589 China Medical Distribution

Market Cap

$638.54 Million

CN¥4.36 Billion CNY

Market Cap Rank

#10830 Global

#2964 in China

Share Price

CN¥2.90

Change (1 day)

+1.75%

52-Week Range

CN¥2.45 - CN¥4.69

All Time High

CN¥17.35